Clanobutin

• CAT Number: R045368
• CAS Number: 30544-61-7
• Molecular Formula: C18H18ClNO4
• Molecular Weight: 347.795
• Purity: ≥95%
• Synonyms: 4-[(4-Chlorobenzoyl)(4-methoxyphenyl)amino]-butanoic Acid; 4-[p-Chloro-N-(p-methoxyphenyl)benzamido]- butyric Acid; Bykahepar; Clanobutine; N-(p-Chlorobenzoyl)-γ-(p-anisidino)butyric acid
• Storage: -20°C
• IUPAC Name: 4-(N-(4-chlorobenzoyl)-4-methoxyanilino)butanoic acid
• InChI: InChI=1S/C18H18ClNO4/c1-24-16-10-8-15(9-11-16)20(12-2-3-17(21)22)18(23)13-4-6-14(19)7-5-13/h4-11H,2-3,12H2,1H3,(H,21,22)
• InChIKey: VUPBWNXFSDRWJE-UHFFFAOYSA-N
• SMILES: COC1=CC=C(C=C1)N(CCCC(=O)O)C(=O)C2=CC=C(C=C2)Cl

Clanobutin, also referred to as danobutyrine, is a medication utilized primarily in the treatment of urinary incontinence and related bladder dysfunctions. Operating as an antispasmodic agent, it works to relax smooth muscles, particularly in the bladder, thereby alleviating symptoms associated with involuntary contractions. Clanobutin targets specific receptors to reduce bladder hyperactivity. It’s commonly prescribed as part of a comprehensive therapeutic approach for conditions like overactive bladder syndrome, enhancing patient comfort.